Products
Online Inquiry
Cot inhibitor-2
Cat. No.:
OB0225WX-1773
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Cot inhibitor-2 is an orally active and potent inhibitor of Tpl2 (MAP3K8) with an IC50 of 1.6 nM, characterized by its ability to suppress LPS-triggered biochemical responses in whole blood.
Synonym:
915363-56-3; 8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-[[[1-(1-ethyl-4-piperidinyl)-1H-1,2,3-triazol-4-yl]methyl]amino]-3-Quinolinecarbonitrile; Wyeth Cot Inhibitor 2; 8-chloro-4-(3-chloro-4-fluoroanilino)-6-[[1-(1-ethylpiperidin-4-yl)triazol-4-yl]methylamino]quinoline-3-carbonitrile; 8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-({[1-(1-ethylpiperidin-4-yl)-1H-1,2,3-triazol-4-yl]methyl}amino)quinoline-3-carbonitrile; 8-Chloro-4-(3-chloro-4-fluoroanilino)-6-({[1-(1-ethylpiperidin-4-yl)-1H-1,2,3-triazol-4-yl]methyl}amino)quinoline-3-carbonitrile; 8-chloro-4-(3-chloro-4-fluoroanilino)-6-[[1-(1-ethyl-4-piperidinyl)-4-triazolyl]methylamino]-3-quinolinecarbonitrile; 8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-({[1-(1-ethylpiperidin-4-yl)-1,2,3-triazol-4-yl]methyl}amino)quinoline-3-carbonitrile
CAS No.:
915363-56-3
Compound CID:
44143370
Formula:
C26H25Cl2FN8
Formula Weight:
539.43
Specification
Targets&IC50:
Cot (Tpl2/MAP3K8): 1.6 nM; TNF-α production (human whole blood): 0.3 μM
Relative Density:
1.45 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Cot inhibitor-2 is used in molecular biology research to explore the regulatory role of Cot kinase in the ERK signaling pathway and its contribution to oncogenic transformation.
Library Information
Target:
MAPK; TNF
Receptor:
MAP3K; TNF-α
Pathways:
Apoptosis; MAPK
Plate Number:
AOCL-23
Plate Location:
f9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
40 mg/mL; 74.15 mM





